Keizo Takenaga

11PUBLICATIONS
20CO-AUTHORS
Medical infection agents (incl. prions)Molecular targetsHaematological tumoursMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 17, 2025
Anticancer Effect of the Triphenylphosphonium-Conjugated Quinolone Antibiotics Targeting Mitochondrial DNA Replication.

Yuming Qiao, Yuki Kida, Xiaoyi Lai

|Aug 02, 2025
Downregulation of sST2, a decoy receptor for interleukin-33, enhances subcutaneous tumor growth in murine pancreatic cancer cells.

Miho Akimoto, Nobuko Koshikawa, Takao Morinaga

|Mar 07, 2025
ATR Inhibition Synergizes With Alkylating PI Polyamide Targeting MYCN by Suppressing DNA Repair in MYCN-Amplified Neuroblastoma.

Xiaoyi Lai, Hiroyuki Yoda, Yuming Qiao

|Jan 22, 2025
Immune evasion through mitochondrial transfer in the tumour microenvironment.

Hideki Ikeda, Katsushige Kawase, Tatsuya Nishi

|Apr 24, 2023
Hypoxia induces downregulation of the tumor-suppressive sST2 in colorectal cancer cells via the HIF-nuclear IL-33-GATA3 pathway.

Miho Akimoto, Takao Susa, Noriyuki Okudaira

|Oct 10, 2022
Anticancer effect of a pyrrole-imidazole polyamide-triphenylphosphonium conjugate selectively targeting a common mitochondrial DNA cancer risk variant in cervical cancer cells.

Jihang Yao, Keizo Takenaga, Nobuko Koshikawa

Pageof 2

Frequent Collaborators

3 joint publications

Hiroki Nagase

3 joint publications

Yusuke Suenaga

3 joint publications

Yasutoshi Tatsumi

3 joint publications

Hideki Ikeda